CRD5: Phase I data

In a 2-week, Canadian Phase I trial in 56 volunteers, CRD5 was safe and well tolerated. Preliminary efficacy data showed CRD5 increased levels of HDL cholesterol by 18%. Also, LDL cholesterol and trig...